These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 3159139)

  • 21. The antifibrinolytic effects of carbon monoxide-releasing molecule-2 are fibrin and alpha2-antiplasmin dependent.
    Nielsen VG
    Blood Coagul Fibrinolysis; 2010 Sep; 21(6):584-7. PubMed ID: 20683324
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Carbon monoxide releasing molecule-2 enhances α2-antiplasmin activity.
    Malayaman SN; Cohen JB; Machovec KA; Bernhardt BE; Arkebauer MR; Nielsen VG
    Blood Coagul Fibrinolysis; 2011 Jun; 22(4):345-8. PubMed ID: 21330914
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gene targeting in hemostasis. Alpha2-antiplasmin.
    Lijnen HR
    Front Biosci; 2001 Feb; 6():D239-47. PubMed ID: 11171550
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased plasmin-alpha2-antiplasmin levels indicate activation of the fibrinolytic system in systemic amyloidoses.
    Bouma B; Maas C; Hazenberg BP; Lokhorst HM; Gebbink MF
    J Thromb Haemost; 2007 Jun; 5(6):1139-42. PubMed ID: 17371485
    [No Abstract]   [Full Text] [Related]  

  • 25. [Molecular structure and function of alpha 2-plasmin inhibitor in blood coagulation and fibrinolysis].
    Nakamura Y; Hirosawa S
    Nihon Rinsho; 1989 Apr; 47(4):851-6. PubMed ID: 2746889
    [No Abstract]   [Full Text] [Related]  

  • 26. Serum antithrombin III and alpha-2-antiplasmin concentration in patients with lung carcinoma.
    Dabrowska M; Prokopowicz J; Kemona H; Kretowska J; Kulik S; Głuszczak M
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(5):641-6. PubMed ID: 2465244
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Blood coagulation mechanism from the viewpoint of molecular biochemistry: Mechanism of fibrinolysis].
    Matsuda T
    Rinsho Byori; 1985 Sep; 33(9):982-8. PubMed ID: 2416968
    [No Abstract]   [Full Text] [Related]  

  • 28. [Plasmin-alpha2 plasmin inhibitor complex (PIC)].
    Yoshikawa Y
    Nihon Rinsho; 2004 Dec; 62 Suppl 12():711-3. PubMed ID: 15658431
    [No Abstract]   [Full Text] [Related]  

  • 29. Clot retraction increases clot resistance to fibrinolysis by condensing alpha 2-plasmin inhibitor crosslinked to fibrin.
    Aoki N
    Thromb Haemost; 1993 Aug; 70(2):376. PubMed ID: 8236154
    [No Abstract]   [Full Text] [Related]  

  • 30. Thrombomodulin-dependent effect of factor V Leiden mutation on the cross-linking of α2-plasmin inhibitor to fibrin and its consequences on fibrinolysis.
    Koncz Z; Bagoly Z; Haramura G; Mezei ZA; Muszbek L
    Thromb Res; 2012 Sep; 130(3):528-34. PubMed ID: 22704462
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of a latex immunoturbidimetric assay for the automated measurement of alpha2 plasmin inhibitor-plasmin complex in human plasma.
    Fujimoto T; Nakamura K; Nishihira J
    Semin Thromb Hemost; 1999; 25(6):551-6. PubMed ID: 10632477
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fibrinolysis and thrombosis of fibrinogen-modified gold nanoparticles for detection of fibrinolytic-related proteins.
    Jian JW; Chiu WC; Chang HT; Hsu PH; Huang CC
    Anal Chim Acta; 2013 Apr; 774():67-72. PubMed ID: 23567118
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enhanced in vitro fibrinolytic activity of immobilized plasmin on collagen beads.
    Shankar H; Senatore F; Zuniga P; Venkataramani E
    J Biomed Mater Res; 1987 Jul; 21(7):897-912. PubMed ID: 2440893
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cross-linking of alpha 2-plasmin inhibitor to fibrin by fibrin-stabilizing factor.
    Sakata Y; Aoki N
    J Clin Invest; 1980 Feb; 65(2):290-7. PubMed ID: 6444305
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The kinetics of plasmin inhibition by aprotinin in vivo.
    Kang HM; Kalnoski MH; Frederick M; Chandler WL
    Thromb Res; 2005; 115(4):327-40. PubMed ID: 15668193
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Evaluation of a latex agglutination assay method for the determination of plasmin/alpha 2 plasmin inhibitor complex].
    Murakami F; Iijima K; Nakamura K; Ikawa S
    Rinsho Byori; 1994 Jun; 42(6):643-7. PubMed ID: 8051804
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased plasma plasmin-α2-plasmin inhibitor complex levels correlate with postoperative rebleeding after endoscopic surgery for spontaneous intracerebral hemorrhage.
    Yagi K; Tao Y; Hara K; Kanda E; Hirai S; Takai H; Kinoshita K; Mimani Y; Miyazaki Y; Oyama N; Yagita Y; Matsubara S; Uno M
    Acta Neurochir (Wien); 2020 Dec; 162(12):3129-3136. PubMed ID: 31781996
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The behavior of alpha2-plasmin inhibitor in fibrinolytic states.
    Aoki N; Moroi M; Matsuda M; Tachiya K
    J Clin Invest; 1977 Aug; 60(2):361-9. PubMed ID: 68962
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Reactions of alpha 2 plasmin inhibitor to plasmin and fibrin; its significance in fibrinolysis inhibition and hemostasis].
    Ichinose A; Sakata Y; Aoki N
    Rinsho Byori; 1982 Jun; Suppl 50():178-88. PubMed ID: 6215510
    [No Abstract]   [Full Text] [Related]  

  • 40. [Purification of plasmin-alpha2-antiplasmin complex by lysine-sepharose 4B affinity chromatography employing sequential elutions].
    Li JX; Zhou Y; Wang H; Zheng ZY; Li D; Wang HL
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2004 Jun; 12(3):355-8. PubMed ID: 15228666
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.